Prot. GS-US-540-5912 A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants with Severely Reduced Kidney Function who are Hospitalized for COVID-19

  • Shetty, Aneesha Anand (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/14/21 → 5/14/24

Funding

  • Gilead Sciences, Inc (Prot# GS-US-540-5912)